VINCI S.A. INH. EO 2,50/ FR0000125486 /
2024-10-04 3:39:05 PM | Chg. +1.9000 | Volume | Bid6:33:13 PM | Ask6:11:39 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
104.5000EUR | +1.85% | 758 Turnover: 79,007.2000 |
104.8000Bid Size: 80 | 105.0500Ask Size: 80 | 61.79 bill.EUR | 4.29% | 12.67 |
GlobeNewswire
06-05
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
06-03
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
GlobeNewswire
05-09
eHealth Exchange Recognized in KLAS Case Study for Advancing Networked FHIR in Provider-Payer Health...
GlobeNewswire
05-02
Jaguar Growth Partners Enters U.S. Market With $24 Million Acquisition of Multi Property Residential...
GlobeNewswire
04-01
Largest Gift in SWBC History Makes Significant Impact on Pediatric Patients Needing Surgical Care
GlobeNewswire
03-27
When Art Meets AI: A Revolutionary Dialogue with Digital Human Mona Lisa on Female Empowerment
GlobeNewswire
03-26
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in S...
Newsfile Corp
03-21
GBSB Global Business School Announces the Appointment of the New Head of Institution and President
GlobeNewswire
03-19
Pluxee reinforces Leadership Team to accelerate the execution of its strategic growth
GlobeNewswire
03-14
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5